Competition law is critical in the context of merger and joint venture deals and global transactions. We are highly expert in structuring deals and designing appropriate remedies to remove any competition concerns. We also advise third parties wishing to act as a complainant against a proposed merger.
‘We have a great network of like-minded firms, because we can use great people who think like us, wherever they may be in the world’
– Marie Leppard, Partner
CLIENTS & CASES
- Imprivata, Global medical technology company, on the competition and public interest aspects of its proposed acquisition of Isosec and subsequent CMA review.
- London Stock Exchange Group on obtaining EU Phase 2 merger clearance with remedies for its merger with Refinitiv
- Siemens and BP in relation to a Joint Venture.
- Statoil Fuel & Retail (now Circle K) on its merger with Shell’s retail fuel network in Denmark before the European Commission.
- PKN Orlen, leading Polish oil company, on obtaining EU Phase 2 merger clearance with remedies for its merger with rival Grupa Lotos.
- Refresco on Phase 1 clearance with remedies for its acquisition of Cott’s bottling activities before the CMA.
- Johnson & Johnson on obtaining EU Phase 2 merger clearance with remedies for its acquisition of Synthes.
- EEX/Powernext as a third-party complainant in the acquisition of Trayport by ICE before the CMA.
- Refresco in relation to notification to the CMA of its proposed buyout by PAI and BCiM.
- CityJet on its long-term wet lease arrangement with Aer Lingus, involving very rare strategic exit rationale.
- Private Equity Houses on mergers, acquisitions and joint ventures in the UK and Europe.